Analysed NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) News Sources
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians
28-07-2026
yahoo.com
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time
03-08-2026
yahoo.com
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Call Highlights: Revenue Grows 16% ...
17-08-2026
yahoo.com
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform
27-08-2026
yahoo.com
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
05-10-2026
yahoo.com
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
08-10-2026
yahoo.com
NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program
22-10-2026
yahoo.com
NeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial Pain
27-10-2026
yahoo.com
What is the current price of NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ)?
The current price of NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) is $0.9272.
NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) since the previous trading day is $-0.0426.
NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) since the previous trading day is -4.3927%.
What is the most recent average sentiment score for NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ)?
The most recent average sentiment score for NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ)?
The most recent sentiment for NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) is .
SEC-8K** Filing Available For NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.